Development of a prognostic model based on anoikis-related genes for predicting clinical prognosis and immunotherapy of hepatocellular carcinoma
Figure 7.Tumor mutational burden and GSEA analysis in risk subgroups. (A, B) Somatic mutation landscape analysis in the risk subgroup. (C, D) GSEA analysis of risk subgroups.